Research

NCT06072898 - A Randomized Neuroimaging Trial of Psilocybin in Depression

Clinical Trial in Toronto, Ontario

The goal of this neuroimaging clinical trial is to test whether psilocybin produces significant immediate changes in functional brain activity in networks associated with mood regulation and depression compared to placebo in patients with depression. The trial aims to determine if psilocybin: 1. Changes connectivity within brain networks associated with mood and depression 2. Changes blood flow in brain regions as... Source record lists lead sponsor Sunnybrook Health Sciences Centre and overall status Recruiting.

Clinical TrialResearch
NCT06072898 - A Randomized Neuroimaging Trial of Psilocybin in Depression

What They List

  • Psilocybin Clinical Trial
  • Study Screening Information
  • Research Participation Details

Directory Facts

Status
Verified from official/source records
Price
Free study screening / research participation
Hours
Verify with provider
License / Record
NCT06072898
Last Verified
2026-06-12

Location

Sunnybrook Health Sciences Centre, Toronto, Ontario

Source Notes

Discovery row generated from the official ClinicalTrials.gov API record for NCT06072898; status Recruiting; sponsor Sunnybrook Health Sciences Centre.

Source: https://clinicaltrials.gov/study/NCT06072898

Informational listing only.

MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.